Subscribe Now
 Already a subscriber? Log-in!
By subscribing to Laboratory Industry Report, each month you'll get an insider's view of the lab industry's most important business and financial trends, plus predictions for the coming year.
In each issue, you find:
- Comparative data on lab pricing
- Information and explanations describing how to deal with healthcare integration, capitation, technology advances, etc.
- Clear perspectives of how your firm is performing vs. the market at large How publicly-traded lab companies are performing and what their top executives earn
- Updates on late-breaking mergers & acquisitions.
Are you up on what's working—and what's not—for laboratories located in a variety of practice settings-hospital, commercial, group practice sites and network systems?
More importantly, do you know where to turn for business intelligence & insight when you need to know what's happening to key companies, how Wall Street views the industry, or the latest scoop on mergers, buyouts, consolidations and alliances?
Laboratory Industry Report is a must for everyone having a vital stake in today's competitive lab marketplace-owner, director, pathologist, CEO, COO, CFO, general manager, administrator, manager, marketeer, or vendor.
With Laboratory Industry Report, you'll get all the business news & insights which are accurate, objective, reliable, and authoritative. Gain a competitive edge for your company or institution today by subscribing today!
|
|
|
 |
 | LIR August 2008 (full PDF issue) |
| TOP OF THE NEWS
Medicare bill yields 4.5% lab fee boost
Global M&A coming in at over $300M
DIGITAL PATHOLOGY OUTLOOK
LIR talks strategy with GE’s Gene Cartwright
INSIDE THE LAB INDUSTRY
MuirLab’s outreach growth reveals key competitive tips
LAB PROFILE
Lakewood Path enters GI market, renamed PLUS Diagnostics
DTC TESTING UPDATE
California is getting tough with DTC makers
FINANCIAL
Lab index up 13% over 13 weeks
INDUSTRY BUZZ
Labs struggle to fill med tech positions
Full Article |
| Global M&A Market Totals Over $300 Million Through First Half of 2008 |
| Sonic Healthcare and LabCorp are leading the global lab merger and acquisition (M&A) market, which is totaling $311.8 million with an average price/revenue multiple of 4.8x so far in 2008 (see table).
Full Article |
| Global M&A Market Totals Over $300 Million Through First Half of 2008 |
| Sonic Healthcare and LabCorp are leading the global lab merger and acquisition (M&A) market, which is totaling $311.8 million with an average price/revenue multiple of 4.8x so far in 2008 (see table).
Full Article |
| Medicare Bill Delivers 4.5% Lab Fee Update in 2009, Repeals Competitive Bidding Demo |
| The laboratory industry has multiple reasons to celebrate the passage of the recent Medicare bill, which was pushed through by an overwhelming Congressional override of President Bush’s veto, notably the repeal of the competitive bidding demonstration project for lab testing services, the reversal of the 10.6 percent reduction in the physician fee schedule, as well as extension of the technical component (TC) grandfather clause for anatomic pathology services for 18 months.
Full Article |
| GE Healthcare Dives Into $2-$4 Billion Digital Pathology Market |
| Omnyx, LLC—the recently announced joint venture between GE Healthcare and the University of Pittsburgh Medical Center (UPMC)—plans to officially enter the digital pathology market when they introduce a benchtop system in 2010.
Full Article |
| John Muir’s Strategies for Outreach Growth Leads to $35 Million New Lab |
| Since Scott Liff arrived at John Muir Health in 1999, the system’s net sales in the outreach laboratory have grown from $13 million to over $50 million a year. Based in Walnut Creek, California, John Muir just opened a new 56,000-square foot core laboratory—called MuirLab—in April. An estimated 3,300 patients per day are serviced by MuirLab, explained Liff, who is the vice president of laboratory services and imaging, at the recent Lab Outreach 2008, held June 18-20, in Las Vegas.
Full Article |
| Lakewood Pathology Enters $1 Billion GI Testing Market, Renamed PLUS Diagnostics |
| Only two years after receiving $50 million in equity financing from Water Street Healthcare Partners in May 2006, Lakewood Pathology Associates has refined its platform business—genitourinary (GU) pathology—and is now entering the gastrointestinal (GI) pathology market, currently valued at between $1 billion and $1.5 billion in the United States. The company is also undergoing a rebranding—as of August 4, the Lakewood, New Jersey-based pathology group will be renamed PLUS Diagnostics.
Full Article |
| Calif. Cease-and-Desist Letters Spark Fear in DTC Testing Industry |
| The California Department of Public Health’s (CDPH) efforts to crack down on direct-to-consumer (DTC) genetic testing in the state is prompting concern among many companies, even those who didn’t receive one of the 13 cease-and-desist letters that the agency sent out in June. Companies that received the letters include personal genomic startups 23andMe (Mountain View, Calif.) and Navigenics (Redwood Shores, Calif.). California appears to be following New York’s lead. Since last November, the New York State Department of Health has sent similar letters to 31 companies, notifying them that they needed to be licensed by the state in order to solicit DNA samples from New York residents.
Full Article |
| Lab Stocks Continue to Show Strength; Index up 13% Over 13 Weeks |
| Now for some good news about the economy: the 14 publicly traded testing companies tracked by the G-2 Laboratory Stock Index continue to inch upward, with the index up 4 percent over the past five weeks and 13 percent over the past 13 weeks for the week ended July 18, 2008. The Nasdaq and S&P 500 continue to fall, however. Both are down over 14 percent compared to a year ago for the week ended July 18.
Full Article |
| Nearly Half of Labs Struggle to Fill Med Tech Positions |
| Almost half of all laboratories in the United States—44 percent—are currently struggling to fill medical technology positions, according to market analysis by Slone Partners (Miami), a recruitment firm specializing in the diagnostic industry that recently launched a med tech search division. Cytogenetic technologists are especially in demand, with many labs surveyed reporting between one and 20 vacancies in their cytogenetic laboratories, according to this analysis. Certified cytogenetic technologists are especially in demand, although some employers will hire recent med tech graduates and offer incentives to achieve certification.
Full Article |
|
|
Please choose an archived issue to view newsletter table of contents above
|
|
